$32.60
00.00%
Pre-Market: Jul 26, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
OrthoPediatrics (NASDAQ:KIDS) Stock, Analyst Ratings, Price Targets, Forecasts
OrthoPediatrics Corp has a consensus price target of $48.33 based on the ratings of 9 analysts. The high is $77 issued by JMP Securities on August 6, 2021. The low is $31 issued by Truist Securities on January 25, 2024. The 3 most-recent analyst ratings were released by Truist Securities, Truist Securities, and JMP Securities on July 16, 2024, May 8, 2024, and May 7, 2024, respectively. With an average price target of $41 between Truist Securities, Truist Securities, and JMP Securities, there's an implied 25.77% upside for OrthoPediatrics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
JMP Securities
Needham
Stifel
Truist Securities
1calculated from analyst ratings
Analyst Ratings for OrthoPediatrics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/16/2024 | Buy Now | 7.36% | Truist Securities | Samuel Brodovsky | $38 → $35 | Maintains | Hold | Get Alert |
| 05/08/2024 | Buy Now | 16.56% | Truist Securities | Samuel Brodovsky | $35 → $38 | Maintains | Hold | Get Alert |
| 05/07/2024 | Buy Now | 53.37% | JMP Securities | David Turkaly | → $50 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/07/2024 | Buy Now | 28.83% | Needham | Mike Matson | $37 → $42 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 13.5% | Needham | Mike Matson | → $37 | Reiterates | Buy → Buy | Get Alert |
| 03/08/2024 | Buy Now | -1.84% | Truist Securities | Samuel Brodovsky | $31 → $32 | Maintains | Hold | Get Alert |
| 03/07/2024 | Buy Now | 4.29% | Stifel | Rick Wise | $32 → $34 | Maintains | Buy | Get Alert |
| 03/07/2024 | Buy Now | 13.5% | Needham | Mike Matson | → $37 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | Buy Now | 53.37% | JMP Securities | David Turkaly | → $50 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/25/2024 | Buy Now | -4.91% | Truist Securities | Kaila Krum | $39 → $31 | Downgrade | Buy → Hold | Get Alert |
| 12/22/2023 | Buy Now | 19.63% | Truist Securities | Richard Newitter | $35 → $39 | Maintains | Buy | Get Alert |
| 12/07/2023 | Buy Now | 53.37% | JMP Securities | David Turkaly | $60 → $50 | Maintains | Market Outperform | Get Alert |
| 11/08/2023 | Buy Now | 7.36% | Truist Securities | Richard Newitter | $31 → $35 | Maintains | Buy | Get Alert |
| 11/07/2023 | Buy Now | 13.5% | Needham | Mike Matson | $55 → $37 | Maintains | Buy | Get Alert |
| 10/04/2023 | Buy Now | 59.51% | BTIG | Ryan Zimmerman | $59 → $52 | Maintains | Buy | Get Alert |
| 09/01/2023 | Buy Now | 84.05% | JMP Securities | David Turkaly | → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/02/2023 | Buy Now | 56.44% | Truist Securities | Richard Newitter | $57 → $51 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | 84.05% | JMP Securities | David Turkaly | → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/01/2023 | Buy Now | 68.71% | Needham | Mike Matson | → $55 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2023 | Buy Now | 68.71% | Needham | Mike Matson | $51 → $55 | Maintains | Buy | Get Alert |
| 05/02/2023 | Buy Now | 84.05% | JMP Securities | David Turkaly | → $60 | Reiterates | → Market Outperform | Get Alert |
| 04/17/2023 | Buy Now | 56.44% | Needham | Mike Matson | → $51 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 74.85% | Truist Securities | Richard Newitter | $53 → $57 | Maintains | Buy | Get Alert |
| 03/01/2023 | Buy Now | 56.44% | Needham | Mike Matson | $50 → $51 | Maintains | Buy | Get Alert |
| 01/31/2023 | Buy Now | 71.78% | Truist Securities | Richard Newitter | $47 → $56 | Maintains | Buy | Get Alert |
| 01/10/2023 | Buy Now | 53.37% | Stifel | Rick Wise | $52 → $50 | Maintains | Buy | Get Alert |
| 11/02/2022 | Buy Now | 84.05% | JMP Securities | David Turkaly | $70 → $60 | Maintains | Market Outperform | Get Alert |
| 11/01/2022 | Buy Now | 53.37% | Needham | Mike Matson | $59 → $50 | Maintains | Buy | Get Alert |
| 10/17/2022 | Buy Now | 59.51% | Truist Securities | Kaila Krum | $66 → $52 | Maintains | Buy | Get Alert |
| 08/05/2022 | Buy Now | 102.45% | Truist Securities | Kaila Krum | $51 → $66 | Maintains | Buy | Get Alert |
| 07/18/2022 | Buy Now | 87.12% | BTIG | Ryan Zimmerman | $65 → $61 | Maintains | Buy | Get Alert |
| 07/18/2022 | Buy Now | 53.37% | Stifel | Rick Wise | $57 → $50 | Maintains | Buy | Get Alert |
| 05/05/2022 | Buy Now | 80.98% | Needham | Mike Matson | $65 → $59 | Maintains | Buy | Get Alert |
| 03/03/2022 | Buy Now | 99.39% | Needham | Mike Matson | $83 → $65 | Maintains | Buy | Get Alert |
| 12/22/2021 | Buy Now | 108.59% | BTIG | Ryan Zimmerman | $75 → $68 | Maintains | Buy | Get Alert |
| 12/21/2021 | Buy Now | 130.06% | Truist Securities | — | $78 → $75 | Maintains | Buy | Get Alert |
| 08/06/2021 | Buy Now | 136.2% | JMP Securities | — | — | Maintains | Market Outperform | Get Alert |
FAQ
What is the target price for OrthoPediatrics (KIDS) stock?
The latest price target for OrthoPediatrics (NASDAQ:KIDS) was reported by Truist Securities on July 16, 2024. The analyst firm set a price target for $35.00 expecting KIDS to rise to within 12 months (a possible 7.36% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for OrthoPediatrics (KIDS)?
The latest analyst rating for OrthoPediatrics (NASDAQ:KIDS) was provided by Truist Securities, and OrthoPediatrics maintained their hold rating.
When was the last upgrade for OrthoPediatrics (KIDS)?
There is no last upgrade for OrthoPediatrics
When was the last downgrade for OrthoPediatrics (KIDS)?
The last downgrade for OrthoPediatrics Corp happened on January 25, 2024 when Truist Securities changed their price target from $39 to $31 for OrthoPediatrics Corp.
When is the next analyst rating going to be posted or updated for OrthoPediatrics (KIDS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OrthoPediatrics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OrthoPediatrics was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
Is the Analyst Rating OrthoPediatrics (KIDS) correct?
While ratings are subjective and will change, the latest OrthoPediatrics (KIDS) rating was a maintained with a price target of $38.00 to $35.00. The current price OrthoPediatrics (KIDS) is trading at is $32.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.